Related Experiment Video

Updated: Jul 8, 2026

Real-time Evaluation of Absolute, Cytosolic, Free Ca2+ and Corresponding Contractility in Isolated, Pressurized Lymph Vessels
08:46

Real-time Evaluation of Absolute, Cytosolic, Free Ca2+ and Corresponding Contractility in Isolated, Pressurized Lymph Vessels

Published on: March 22, 2024

[Effect of nifedipine on organ protection: potential application in patients with aortic aneurysm]

Ryuichi Morishita1, Naruya Tomita

  • 1Division of Clinical Gene Therapy, Osaka University Graduate School of Medicine, Osaka, Japan.

Drugs
|January 19, 2008
PubMed

Insights

Nifedipine may help treat aortic aneurysms by inhibiting key cellular pathways involved in their growth. This drug shows potential for reducing aneurysm extension, independent of its blood pressure-lowering effects.

Area of Science:

  • Cardiovascular Research
  • Pharmacology
  • Cellular Biology

Context:

  • Aortic aneurysms represent a significant health concern with limited effective drug therapies.
  • Hypertension is a known risk factor, but cellular mechanisms involving nuclear factor-kappaB (NF-kappaB) and matrix metalloproteinase (MMP) are implicated in aneurysm progression.

Purpose:

  • To evaluate the efficacy of nifedipine in a rat model of aortic aneurysm.
  • To investigate the effects of nifedipine on NF-kappaB and MMP activation in the context of aortic aneurysm.

Summary:

  • Nifedipine demonstrated an ability to inhibit both MMP activation and aortic aneurysm extension in a rat model.
  • The drug also suppressed NF-kappaB activation, with these effects being distinct from its antihypertensive properties.

Impact:

  • Nifedipine exhibits potential as a therapeutic agent for aortic aneurysms, offering both antihypertensive and vasculoprotective benefits.
  • Its demonstrated inhibition of NF-kappaB and MMP activation suggests a novel mechanism for managing aortic aneurysm progression.

Related Concept Videos

Antianginal Drugs: Nitrates and β-Blockers01:16

Antianginal Drugs: Nitrates and β-Blockers

In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates,  such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Aortic Regurgitation IV: Nursing Management01:17

Aortic Regurgitation IV: Nursing Management

A nurse managing a patient with aortic regurgitation begins with a comprehensive assessment, including a review of the patient's medical history, family history, and lifestyle factors. During the cardiac examination, the nurse listens for heart sounds and checks for signs of valve abnormalities. The nurse also observes for symptoms such as dyspnea, orthopnea, and paroxysmal nocturnal dyspnea and assesses the patient's endurance and daily activity tolerance.Based on the findings, the nurse...
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...